News

EdgeCap acquiert une participation majoritaire dans Comac Medical, le fondateur conservant une participation minoritaire significative

by

LONDRES, 9 juin 2023 /PRNewswire/ — Comac Medical (Comac ou la Société) a annoncé aujourd’hui que des fonds conseillés par EdgeCap Partners (EdgeCap) ont acquis une participation majoritaire dans la Société. Le fondateur et PDG de Comac, Dr Milen Vrabevski, ainsi que d’autres actionnaires, ont conservé une participation minoritaire significative et continueront à assumer leurs rôles … Read more

Global Photon Counter Market to Surpass USD 3.36 Billion By 2031| Growth Market Reports

by

PUNE, India, June 9, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Global Photon Counter Market Segments – by Types (Basic Types, Background Compensation Types, and Radiation Source Compensation Types), Primary Materials (Cadmium Telluride (CdTe), Cadmium Zinc Telluride (CZT), and Silicon (Si)), Application (Medical Applications and Non-Medical Industrial … Read more

MindSite News announces a live online panel on June 15: “Breaking Away from Hate”

by

– Former white supremacists, a deradicalization specialist, and a psychiatry professor discuss how to help get people out of violent hate groups – Thursday June 15 | 10:00am PT / 1:00pm ET – Register below OAKLAND, Calif., June 9, 2023 /PRNewswire/ — Reporter Laurie Udesky was in her early 20s when a neo-Nazi organization decided … Read more

Global Multivitamins Supplements to Surpass USD 2.7 Billion By 2031| Growth Market Reports

by

PUNE, India, June 9, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, ” Global Multivitamins Supplements Market Segments – By Type (Premium Multi-Vitamins and Mass Multi-Vitamins), By Form (Capsule, Tablet, Gummies, Powder, and Liquid), By Target Gender & Age Group (Labeled Men and Labeled Women), By Distribution Channel (Offline and Online), and … Read more

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares

by

LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK. His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia.  About Immunovia Immunovia is a diagnostic company with the vision to revolutionize … Read more

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares

by

LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK. His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia.  About Immunovia Immunovia is a diagnostic company with the vision to revolutionize … Read more

Medical diagnostics market size is set to grow by USD 74.58 billion from 2022-2027; The high prevalence of infectious diseases will boost the market- Technavio

by

NEW YORK, June 9, 2023 /PRNewswire/ — The global medical diagnostics market size is estimated to grow by USD 74.58 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 6.15%. The growth momentum will be progressing during the forecast period. Asia is estimated to contribute to 38% of the market growth … Read more

DoH and MSD GCC expand partnership during BIO International Convention 2023 to advance research in Oncology

by

ABU DHABI, UAE , June 9, 2023 /PRNewswire/ — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a new Memorandum of Understanding (MoU) with leading global biopharmaceutical company MSD GCC, to advance research into breast and lung cancer. DoH MoU with MSD GCC DoH MoU with … Read more

AbbVie’s VENCLYXTO®/VENCLEXTA® (venetoclax) Continues to Show Sustained Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) Patients

by

Data from two studies continue to show the long-term efficacy and safety of fixed-duration venetoclax combination regimens across different lines of therapy in CLL Six-year median follow-up from the Phase 3 CLL14 study shows continued PFS after treatment with venetoclax plus obinutuzumab compared to treatment with chlorambucil plus obinutuzumab in previously untreated patients with CLL … Read more

Medical Billing Outsourcing Market size to grow by USD 11,704.49 million from 2022 to 2027; The improvement in healthcare administrative processes, optimization, and operational efficiency will drive the market growth

by

NEW YORK, June 9, 2023 /PRNewswire/ — The global medical billing outsourcing market size is estimated to increase by USD 11,704.49 million from 2022 to 2027. The market’s growth momentum will be progressing at a CAGR of 15.73%. Discover some insights on market size, historic period (2017 to 2021), and Forecast (2023 to 2027) before buying the full report – Request a … Read more